Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dandan Lin, Yu Mei, Lei Lei, Zuhairah Binte Hanafi, Ziqi Jin, Yonghao Liu, Yuan Song, Yinsheng Zhang, Bo Hu, Chunliang Liu, Jinhua Lu & Haiyan Liu. (2022) Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1. OncoImmunology 11:1.
Read now
Read now
Yuan Zhuang, Chang Liu, Jiaqing Liu & Guang Li. (2020) Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle. OncoTargets and Therapy 13, pages 83-94.
Read now
Read now
Muluneh Ademe. (2020) Paradoxes in the Phenotype, Frequency and Roles of Myeloid-Derived Suppressor Cells During HIV Infection. HIV/AIDS - Research and Palliative Care 12, pages 151-156.
Read now
Read now
Articles from other publishers (34)
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang & Nariman Nezami. (2023) Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15:9, pages 2624.
Crossref
Crossref
Maria Papanastasatou & Mihalis Verykokakis. (2023) Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 14.
Crossref
Crossref
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce & Palma Fedele. (2023) Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 15:3, pages 654.
Crossref
Crossref
Zhao-Shan Niu, Wen-Hong Wang & Xiao-Jun Niu. (2022) Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World Journal of Gastroenterology 28:46, pages 6433-6477.
Crossref
Crossref
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane & Lionel Hebbard. (2022) Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 86, pages 799-815.
Crossref
Crossref
Dazhi Tian, Yang Yu, Li Zhang, Jisan Sun & Wentao Jiang. (2022) 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Anti-Cancer Drugs 33:9, pages 815-825.
Crossref
Crossref
Shuai Chen, Jianghong Cheng, Yanhong Zhong, Ruimin Liu, Zhongxian Lu & Xianyang Luo. (2022) Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells. Oncogene 41:24, pages 3316-3327.
Crossref
Crossref
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, Ludovica Ceci, Leonardo Baiocchi, Lindsey Kennedy, Sanjukta Chakraborty, Shannon Glaser, Heather Francis, Gianfranco Alpini & Keisaku Sato. (2022) The Functional Roles of Immune Cells in Primary Liver Cancer. The American Journal of Pathology 192:6, pages 826-836.
Crossref
Crossref
Hui Li. (2022) Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Digestive and Liver Disease 54:5, pages 598-613.
Crossref
Crossref
Xiaoqiang Yin, Tongchui Wu, Yadong Lan & Wulin Yang. (2022) Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma. Bioscience Reports 42:2.
Crossref
Crossref
Adeleye O. Adeshakin, Funmilayo O. Adeshakin, Dehong Yan & Xiaochun Wan. (2022) Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Raquel Muñoz, Alessandra Girotti, Denise Hileeto & Francisco Javier Arias. (2021) Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment. Cancers 13:21, pages 5414.
Crossref
Crossref
Dev Karan. (2021) CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Jie Chen, Yong-Jian Chen, Nan Jiang, Jian-Liang Xu, Zi-Ming Liang, Ming-Jun Bai, Yan-Fang Xing, Zhuo Liu, Xiang-Yuan Wu & Xing Li. (2021) Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. The Oncologist 26:8, pages e1434-e1444.
Crossref
Crossref
Ying Wang, Karthik Tiruthani, Sirui Li, Mengying Hu, Guojie Zhong, Yu Tang, Sourav Roy, Lillian Zhang, Jun Tan, Chengheng Liao & Rihe Liu. (2021) mRNA Delivery of a Bispecific Single‐Domain Antibody to Polarize Tumor‐Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced Materials 33:23, pages 2007603.
Crossref
Crossref
Yueqi Zhang, Hongbing Wang & Hua Xiao. (2021) Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC. International Journal of Molecular Sciences 22:9, pages 5016.
Crossref
Crossref
Jessica K. Mandula & Paulo C. Rodriguez. (2021) Tumor-related stress regulates functional plasticity of MDSCs. Cellular Immunology 363, pages 104312.
Crossref
Crossref
Latika Singh, Eric S. Muise, Anannya Bhattacharya, Jeff Grein, Sarah Javaid, Peter Stivers, Jun Zhang, Yujie Qu, Barbara Joyce-Shaikh, Andrey Loboda, Chunsheng Zhang, Michael Meehl, Derek Y. Chiang, Sheila H. Ranganath, Michael Rosenzweig & Philip E. Brandish. (2021) ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells. Molecular Cancer Research 19:4, pages 702-716.
Crossref
Crossref
Tsz Tung Kwong, Chi Hang Wong, Jing Ying Zhou, Alfred Sze Lok Cheng, Joseph Jao Yiu Sung, Anthony Wing Hung Chan & Stephen Lam Chan. (2021) Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade. JHEP Reports 3:2, pages 100224.
Crossref
Crossref
Suresh Gopi Kalathil & Yasmin Thanavala. (2021) Importance of myeloid derived suppressor cells in cancer from a biomarker perspective. Cellular Immunology 361, pages 104280.
Crossref
Crossref
Astha Malik, Unmesha Thanekar, Surya Amarachintha, Reena Mourya, Shreya Nalluri, Alexander Bondoc & Pranavkumar Shivakumar. (2021) “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Maham Farshidpour, Monjur Ahmed, Shilpa Junna & Juanita L Merchant. (2021) Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review. World Journal of Gastrointestinal Oncology 13:1, pages 1-11.
Crossref
Crossref
Peiwen Chen, Wen-Hao Hsu, Jincheng Han, Yan Xia & Ronald A. DePinho. (2021) Cancer Stemness Meets Immunity: From Mechanism to Therapy. Cell Reports 34:1, pages 108597.
Crossref
Crossref
Alex L. Wilkinson, Maria Qurashi & Shishir Shetty. (2020) The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Frontiers in Physiology 11.
Crossref
Crossref
Wenzhe Yin, Jun Xu, Chao Li, Xiankui Dai, Tong Wu & Jifeng Wen. (2020) Plantamajoside inhibits the proliferation and epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia‐inducible factor‐1α‐dependent gene expression. Cell Biology International 44:8, pages 1616-1627.
Crossref
Crossref
Changpei Cheng, Qiyang Shou, Jiali Lang, Lu Jin, Xia Liu, Dongxin Tang, Zhu Yang & Huiying Fu. (2020) Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment. Frontiers in Pharmacology 11.
Crossref
Crossref
Stephen P Hack, Jessica Spahn, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow & Shukui Qin. (2020) IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. Future Oncology 16:15, pages 975-989.
Crossref
Crossref
Francesca Finetti, Nagaja Capitani, Noemi Manganaro, Vanessa Tatangelo, Francesca Libonati, Giulia Panattoni, Ivo Calaresu, Laura Ballerini, Cosima T. Baldari & Laura Patrussi. (2020) Optimization of Organotypic Cultures of Mouse Spleen for Staining and Functional Assays. Frontiers in Immunology 11.
Crossref
Crossref
Sean H. Colligan, Stephanie L. Tzetzo & Scott I. Abrams. (2020) Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity. Molecular Immunology 118, pages 165-173.
Crossref
Crossref
Takahiro Kodama & Tetsuo Takehara. 2020. Liver Immunology. Liver Immunology
505
524
.
Eleni-Kyriaki Vetsika, Aristeidis Koukos & Athanasios Kotsakis. (2019) Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer. Cells 8:12, pages 1647.
Crossref
Crossref
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers & Ravi P. Sahu. (2019) Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers 11:11, pages 1627.
Crossref
Crossref
Sabina I. Hlavaty, Yu-Mei Chang, Rachel P. Orth, Mark Goulian, Paul J. Planet, Douglas H. Thamm, Jennifer A. Punt & Oliver A. Garden. (2019) Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs. Frontiers in Immunology 10.
Crossref
Crossref
Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Alexander Lim & Richard Kim. (2019) Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?. Cancers 11:8, pages 1078.
Crossref
Crossref